Hematology/Oncology

Top Story

Survey: American physicians satisfied with career choice despite challenges

March 30, 2017

A survey of 1,200 American physicians, residents and medical students found that nine out of 10 physicians are satisfied with their career choice despite common challenges, according to a press release from the AMA.

The AMA conducted the survey in February and concluded respondents are dealing with administrative burdens, stress and lack of time. For residents, the major challenges included long hours and on-call schedules.

Healio.com introduces Learn Immuno-Oncology

March 30, 2017
Healio.com — the online home of HemOnc Today — has launched LearnImmunoOncology.com, a curriculum-based online resource that offers physicians a guide for…
FDA News

FDA grants priority review to Blincyto for expanded ALL indication

March 30, 2017
The FDA granted priority review to blinatumomab to expand its indication to include all patients with relapsed or refractory B-cell precursor acute lymphoblastic…

Phase 2b study of iobenguane I 131 shows promise for rare neuroendocrine tumors

March 30, 2017
The registrational phase 2b trial designed to evaluate iobenguane I 131 injection for the treatment of malignant and recurrent pheochromocytoma or paraganglioma met its…
In the Journals PlusPerspective

PTC recurrence similar after hemithyroidectomy, thyroidectomy

March 30, 2017
Researchers observed no substantial difference in papillary thyroid carcinoma recurrence rate over 7 years of follow-up between adults who underwent hemithyroidectomy…
More News Headlines »
CME

Management of Multiple Myeloma: Using Emerging Therapies with ASCT

This activity is supported by educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Spectrum Pharmaceuticals, Inc.; and Takeda Oncology.

Multiple myeloma management has undergone profound changes in the past few decades, this is largely due to advances in…
More »
Video
Meeting News

VIDEO: New immune targets may improve advanced melanoma outcomes

March 25, 2017
More »
Featured
HEMONC TODAY Melanoma and Cutaneous Malignancies

HEMONC TODAY Melanoma and Cutaneous Malignancies

CME

Hot Topics in Metastatic Breast Cancer Management: Clinical Advances with CDK4/6 Inhibitors

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

While the mortality rates for advanced or metastatic breast cancer (MBC) have steadily decreased, in part due to…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement